Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
0.63
-0.02 (-3.06%)
At close: Jun 05, 2025, 3:59 PM
0.64
1.11%
After-hours: Jun 05, 2025, 04:00 PM EDT
-3.06% (1D)
| Bid | 0.63 |
| Market Cap | 11.75M |
| Revenue (ttm) | 59.13M |
| Net Income (ttm) | -20.34M |
| EPS (ttm) | -1.8 |
| PE Ratio (ttm) | -0.35 |
| Forward PE | -1.3 |
| Analyst | n/a |
| Ask | 0.66 |
| Volume | 13,635 |
| Avg. Volume (20D) | 53,701 |
| Open | 0.65 |
| Previous Close | 0.65 |
| Day's Range | 0.63 - 0.65 |
| 52-Week Range | 0.48 - 3.55 |
| Beta | 0.81 |
About TRIB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRIB
Website n/a
Next Earnings Release
Trinity Biotech is scheduled to release its earnings on Jun 17, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+78.95%
Trinity Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
7 months ago
+5.46%
Trinity Biotech shares are trading higher after the company announced the acquisition of EpiCapture. Also, the company announced a strategic investment in Novus Diagnostics to advance development and commercialization of Novus' point-of-care diagnostic solutions.
